Business Insider

BRIEF-Jaguar Animal Health announces final topline results for study on Secretory Diarrhea in dogs

* Jaguar Animal Health announces final topline results for proof-of-concept study for Secretory Diarrhea in dogs * Jaguar Animal Health - estimated 200 dogs will be enrolled in Canalevia pivotal study ...
Fox 5 San Diego

Crofelemer, Jaguar Health’s Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company’s Investigational ...

Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved ...
Nasdaq

Diarrhea In Dogs: Complete Guide

Dealing with diarrhea in dogs is no fun. Some dogs are more prone to getting diarrhea than others, as a sensitive stomach could be triggered by their regular diet or scraps of human food. Diarrhea in ...
The Indianapolis Star

Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”) today announced that it received notice from the U.S. Food and Drug Administration’s Center ...
Nasdaq

Jaguar Health Provides Updates on Canalevia (Crofelemer), the First Plant-based Prescription Medicine Under Development for Chemotherapy-induced Diarrhea in Dogs and Exercise ...

SAN FRANCISCO, CA / ACCESSWIRE / May 18, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided updates regarding the development program for the Company's oral ...